Assessing the usability of the BreatheSuite MDI among patients with COPD and Asthma

Assessing the usability of the BreatheSuite MDI among patients with COPD and Asthma

BreatheSuite is pleased to announce the findings of a recently study which demonstrated the usability effectiveness of the BreatheSuite MDI device and app. Our app was determined to be both clear & accessible for people using inhalers for the treatment of #asthma and #COPD, with the potential to improve their management of chronic lung diseases. This study examined 15 participants across a number of use case scenarios involving their metered-dose-inhalers (MDIs) and BreatheSuite's app and add-on. Our findings:

  • All participants correctly completed a dose simulation using the Bluetooth device with no errors
  • All participants were able to review their results correctly on the BreatheSuite app with no errors

Across these scenarios, these participants continuously demonstrated the usability of the BreatheSuite MDI add-on device and app, as well as determining it could be used to help improve their chronic disease management.

For more information, click below to download our complete white paper!
x

Download our Case Study

Click Here
Thank you! You can now downoad our Case Study!
Oops! Something went wrong while submitting the form.
DOWNLOAD OUR WHITE PAPERDOWNLOAD OUR CASE STUDYMEET WITH US TO LEARN MORE
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Back to Newsroom
Cookie Notice
Please know that cookies are required to operate and enhance our products and services, as well as for advertising and analytical purposes. We value your privacy. If you are not comfortable with us collecting and using cookies, please review your settings before continuing.
Our Privacy Policy
Accept